In an urgent move towards expanding the COVID-19 diagnostics in India, the Indian Council of Medical Research (ICMR) has invited quotations from manufacturers for supply of kits for testing.
The move comes in the wake of the number of COVID-19 cases crossing the 600 mark in the country with 13 deaths recorded so far.
According to the apex health research body, it will procure seven lakh US FDA-EUA/CE-IVD/ICMR-NIV Pune-approved RNA extraction kits.
Any manufacturer with an Indian-based supplier can submit quotations by Thursday 2.30 pm, the ICMR said.
The kits have to be supplied to the ICMR’s regional facilities at Mumbai, Delhi, Dibrugarh, Chennai, Hyderabad and Bhopal.
The ICMR has asked the kit manufacturers to quote the prices of the kits, along with the number of tests that can be performed with one kit. It has also sought to know the timeline for the supply of the seven lakh kits.
Also read: Test, test, test for the virus
“The ICMR has estimated a tentative requirement of 7,00,000 test kits for which quotations are invited. The requirement is to ensure supply as soon as possible. Hence, please quote your maximum supply capability in the first week, along with a firm commitment for subsequent weeks,” it said.
It added that it might opt for parallel contracts to more than one vendor to ensure a timely supply.